20 participants were recruited and divided into two groups according to gender -- 11 women and 9 men.
Click here to read more...
42 participants completing a weekly 51-point symptom questionnaire while using Neurotransmitter Precursors.
Click here to read more...
Sixteen female participants partook in this double-blinded study examining the effect of taking CraniYums over a six-week period on 23 associated symptoms of Neurotransmitter Deficiencies.
Click here to read more...
CraniYums™ Laboratory Measurements and Clinical Study Results:
- Serotonin and Dopamine levels substantially and safely increased within one hour of dosing.
- Clinical Study participants reported 39% improvement of symptoms within 2 weeks
and 90% improvement after 4 weeks of consistent use.